Dogwood Therapeutics Pre-Tax Income 2020-2024 | DWTX

Dogwood Therapeutics pre-tax income from 2020 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.

Dogwood Therapeutics Pre-Tax Income 2020-2024 | DWTX

Dogwood Therapeutics pre-tax income from 2020 to 2024. Pre-tax income can be defined as company's earnings or loss before taxes on income have been accounted for.
Related Stocks
Company NameMarket
Cap
Amgen (AMGN)$174.7B
Vertex Pharmaceuticals (VRTX)$125B
Regeneron Pharmaceuticals (REGN)$112.1B
Bristol Myers Squibb (BMY)$107B
Gilead Sciences (GILD)$106.8B
CSL (CSLLY)$97.4B
GSK (GSK)$80.7B
Alnylam Pharmaceuticals (ALNY)$36.9B
Argenex SE (ARGX)$32.6B
BioNTech SE (BNTX)$27.9B
Biogen (BIIB)$27.9B
Illumina (ILMN)$23.5B
Moderna (MRNA)$22B
BeiGene (BGNE)$21.7B
Genmab (GMAB)$15.3B
BioMarin Pharmaceutical (BMRN)$13.4B
Exact Sciences (EXAS)$12.9B
Vaxcyte (PCVX)$12.9B
Insmed (INSM)$12.8B
Incyte (INCY)$12.8B
Sarepta Therapeutics (SRPT)$11.8B
Bio-Techne Corp (TECH)$11.7B
QIAGEN (QGEN)$10B
Bio-Rad Laboratories (BIO.B)$9.3B
Roivant Sciences (ROIV)$8.8B
Legend Biotech (LEGN)$8.2B
Revolution Medicines (RVMD)$8.2B
Exelixis (EXEL)$8.1B
Repligen (RGEN)$8.1B
Intra-Cellular Therapies (ITCI)$7.9B